Disopyramide and Ombitasvir: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Disopyramide
Ombitasvir
No brand names on recordHow we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Increased concentration of the antiarrhythmic agent
Interaction Deep Dive
Concomitant use of ombitasvir and an antiarrhythmic agent may result in increased plasma concentrations of the antiarrhythmic. Use caution if coadministered. Therapeutic concentration monitoring of the antiarrhythmic (if available) is recommended21. Monitor for increased adverse events associated with the antiarrhythmic.
Why it happens (mechanism)
An unknown mechanism
Common questions
Can I take Disopyramide and Ombitasvir together?
Increased concentration of the antiarrhythmic agent Always confirm with your pharmacist or prescriber before making any change.
How serious is the Disopyramide and Ombitasvir interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Disopyramide or Ombitasvir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: VIEKIRA PAK oral tablets, ombitasvir paritaprevir ritonavir oral tablets and dasabuvir oral tablets. AbbVie Inc. (per manufacturer), North Chicago, Il, 2014.
- Product Information: TECHNIVIE(TM) oral tablets, ombitasvir paritaprevir ritonavir oral tablets. AbbVie Inc. (per Manufacturer), North Chicago, IL, 2015.
Keep reading about Disopyramide
Keep reading about Ombitasvir
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist